Changes in mandibular radiomorphometric indices in osteoporosis patients treated with denosumab: a retrospective case-control study.

Valentina Prevolnik-RupelChiara Dal BroiGiulia OttavianiLaura BellassaiTheodora Magdalena Bogdan PredaRoberto Di LenardaMatteo Biasotto

Published in: BMC oral health (2024)

Our results show how CMW shows sufficient sensitivity and specificity to be used as a radiographic marker to screen and intercept patients with osteoporosis. PMI seems to be able to reflect changes in response to antiresorptive therapy with denosumab. Further studies are needed to confirm our hypothesis.

Keyphrases

bone mineral density
postmenopausal women
body composition
high throughput
giant cell
case control
stem cells
mesenchymal stem cells
cell therapy